Pacira Biosciences, Inc. (PCRX)
36.33
-0.07
(-0.19%)
USD |
NASDAQ |
Oct 15, 16:00
36.30
-0.03
(-0.08%)
After-Hours: 20:00
Pacira Biosciences Cash from Operations (TTM) : 187.66M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 187.66M |
| March 31, 2026 | 142.22M |
| December 31, 2025 | 151.99M |
| September 30, 2025 | 141.44M |
| June 30, 2025 | 134.52M |
| March 31, 2025 | 175.75M |
| December 31, 2024 | 189.39M |
| September 30, 2024 | 203.84M |
| June 30, 2024 | 194.36M |
| March 31, 2024 | 184.62M |
| December 31, 2023 | 154.65M |
| September 30, 2023 | 149.10M |
| June 30, 2023 | 147.32M |
| March 31, 2023 | 133.62M |
| December 31, 2022 | 145.27M |
| September 30, 2022 | 126.45M |
| June 30, 2022 | 144.08M |
| March 31, 2022 | 144.41M |
| December 31, 2021 | 125.72M |
| September 30, 2021 | 149.17M |
| June 30, 2021 | 128.66M |
| March 31, 2021 | 82.90M |
| December 31, 2020 | 77.03M |
| September 30, 2020 | 56.27M |
| June 30, 2020 | 34.84M |
| Date | Value |
|---|---|
| March 31, 2020 | 73.23M |
| December 31, 2019 | 70.52M |
| September 30, 2019 | 65.84M |
| June 30, 2019 | 64.11M |
| March 31, 2019 | 55.06M |
| December 31, 2018 | 48.87M |
| September 30, 2018 | 44.58M |
| June 30, 2018 | 25.14M |
| March 31, 2018 | 15.09M |
| December 31, 2017 | 17.78M |
| September 30, 2017 | 18.20M |
| June 30, 2017 | 32.70M |
| March 31, 2017 | 36.58M |
| December 31, 2016 | 33.45M |
| September 30, 2016 | 33.14M |
| June 30, 2016 | 24.27M |
| March 31, 2016 | 25.38M |
| December 31, 2015 | 27.76M |
| September 30, 2015 | 23.87M |
| June 30, 2015 | 29.96M |
| March 31, 2015 | 31.89M |
| December 31, 2014 | 26.44M |
| September 30, 2014 | 6.997M |
| June 30, 2014 | -11.29M |
| March 31, 2014 | -35.28M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Viatris, Inc. | 2.331B |
| Johnson & Johnson | -- |
| Liquidia Corp. | 167.71M |
| Organon & Co. | 737.00M |
| ANI Pharmaceuticals, Inc. | 189.47M |